Penwest Pharmaceuticals Co. (PPCO) Has Made Sound Business Progress in 2007
The company has made significant business progress during 2007. Firstly, it has crossed important regulatory hurdles by including new intellectual properties in the relevant listing of the US Food and Drug Administration (FDA). Secondly, its 2006 collaborative drug launch with a pharmaceutical marketing company has earned respectable market share during 2007. Finally, the company management has structured its clinical trial program to deliver potentially profitable, developmental products into a rich pipeline of possibilities. The stock derives structural strength from the management’s ability to engage in fruitful collaborations with industry partners. Apart from its tie-up with a pharmaceutical marketing firm, the…